| 摘要 |
The present invention relates to compounds of formual (I): wherein Y is a single bond or double bound; and R1 is —C(CH3)C2H5 or —C(CH3)═CHCH3, when Y is a single bound; R1 is —C(CH3)═CH2, is —C(CH3)2, —C(CH3)═CHCH3, —C(CH3)C2H5, or —CH2C(CH3)2, when Y is a double bound. These compounds are bombesin receptor subtype 3 (BRS3) modulating agents, more specifically that they are BRS3 agonists. The invention is also related to the use of such compounds to treat diseases associated with inappropriate BRS3 activity. |
